Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [(211)At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care
在即将开展的[(211)At]At-抗CA-IX抗体(ATO-101™)膀胱内灌注治疗对标准疗法无效的非肌层浸润性膀胱癌患者的研究之前，首先需要进行临床前和临床可行性研究。
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17071190
Rousseau, Caroline; Baumgartner, Pierre; Heymann, Marie-Françoise; Taupin, Manon; Geffroy, Maïwenn; Chatal, Jean-François; Gautier, Gaëlle; Allam, Nadia; Gaschet, Joëlle; Eychenne, Romain; Guérard, François; Gestin, Jean-François; Varmenot, Nicolas; Chérel, Michel
